Xiaoxiang Zhou
- Topics
- Cancer Immunotherapy and Biomarkers (5 papers)Pancreatic and Hepatic Oncology Research (3 papers)RNA modifications and cancer (3 papers)
- Cited by
- OncologyImmunologyHepatology
- Journals
- Nucleic Acids ResearchThe Lancet OncologyInternational Journal of Biological Macromolecules
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaoxiang Zhou
18 papers receiving 761 citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 514
- Immunology 188
- Pulmonary and Respiratory Medicine 176
- Surgery 124
- Molecular Biology 122
Countries citing papers authored by Xiaoxiang Zhou
This map shows the geographic impact of Xiaoxiang Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxiang Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxiang Zhou more than expected).
Fields of papers citing papers by Xiaoxiang Zhou
This network shows the impact of papers produced by Xiaoxiang Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxiang Zhou. The network helps show where Xiaoxiang Zhou may publish in the future.
Co-authorship network of co-authors of Xiaoxiang Zhou
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxiang Zhou. A scholar is included among the top collaborators of Xiaoxiang Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxiang Zhou. Xiaoxiang Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 0 | |
| 7 | 8 | |
| 8 | 2 | |
| 9 | Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysisbreakdown → | 160 |
| 10 | 249 | |
| 11 | 57 | |
| 12 | 24 | |
| 13 | 1 | |
| 14 | 3 | |
| 15 | 56 | |
| 16 | 31 | |
| 17 | 98 | |
| 18 | 58 | |
| 19 | 10 | |
| 20 | 3 |
About Xiaoxiang Zhou
Xiaoxiang Zhou is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 20 papers that have together received 766 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Pancreatic and Hepatic Oncology Research (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Oncology (514 citations), Immunology (188 citations) and Hepatology (46 citations). Xiaoxiang Zhou has collaborated with scholars based in China and United States. Frequent co-authors include Zhuoran Yao, Xuan Zhang, Huaxia Yang, Naixin Liang, Fengchun Zhang, Lejia Sun, Huayu Yang, Yilei Mao, Gang Xu and Meixi Liu. Their work appears in journals such as Nucleic Acids Research, The Lancet Oncology and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.